Rovalpituzumab tesirine
id:
rovalpituzumab-tesirine-291-10227623
title:
Rovalpituzumab tesirine
text:
Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased by AbbVie. It was tested for use in small-cell lung cancer, but development was terminated after unsuccessful phase III trial.
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental antibody-drug conjugate
original url:
https://en.wikipedia.org/wiki/Rovalpituzumab_tesirine
date created:
date modified:
2023-11-29T01:44:19Z
main entity:
{"identifier":"Q30314129","url":"https://www.wikidata.org/entity/Q30314129"}
image:
fields total:
13
integrity:
14